vs
Side-by-side financial comparison of MEDICAL PROPERTIES TRUST INC (MPW) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
MEDICAL PROPERTIES TRUST INC is the larger business by last-quarter revenue ($270.3M vs $151.7M, roughly 1.8× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 6.5%, a 1.3% gap on every dollar of revenue. On growth, MEDICAL PROPERTIES TRUST INC posted the faster year-over-year revenue change (16.6% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -0.2%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
MPW vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.3M | $151.7M |
| Net Profit | $17.6M | $11.8M |
| Gross Margin | 95.8% | 30.4% |
| Operating Margin | 9.7% | 20.4% |
| Net Margin | 6.5% | 7.8% |
| Revenue YoY | 16.6% | -41.1% |
| Net Profit YoY | 104.3% | -80.8% |
| EPS (diluted) | $0.03 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.3M | $151.7M | ||
| Q3 25 | $237.5M | $267.8M | ||
| Q2 25 | $240.4M | $244.0M | ||
| Q1 25 | $223.8M | $211.8M | ||
| Q4 24 | $231.8M | $257.6M | ||
| Q3 24 | $225.8M | $78.8M | ||
| Q2 24 | $266.6M | $76.1M | ||
| Q1 24 | $271.3M | $67.5M |
| Q4 25 | $17.6M | $11.8M | ||
| Q3 25 | $-77.7M | $55.4M | ||
| Q2 25 | $-98.4M | $-17.7M | ||
| Q1 25 | $-118.3M | $21.2M | ||
| Q4 24 | $-412.3M | $61.6M | ||
| Q3 24 | $-801.2M | $-8.8M | ||
| Q2 24 | $-320.6M | $-364.0K | ||
| Q1 24 | $-875.6M | $-364.0K |
| Q4 25 | 95.8% | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | 91.8% | 51.2% | ||
| Q1 25 | 63.6% | 55.9% | ||
| Q4 24 | 90.9% | 55.0% | ||
| Q3 24 | 96.5% | 27.8% | ||
| Q2 24 | 98.4% | 29.7% | ||
| Q1 24 | 84.9% | 15.1% |
| Q4 25 | 9.7% | 20.4% | ||
| Q3 25 | -28.0% | 48.7% | ||
| Q2 25 | -36.7% | 13.8% | ||
| Q1 25 | -48.5% | 38.1% | ||
| Q4 24 | -173.7% | 44.4% | ||
| Q3 24 | -350.7% | 12.3% | ||
| Q2 24 | -114.5% | 7.0% | ||
| Q1 24 | -318.6% | 2.1% |
| Q4 25 | 6.5% | 7.8% | ||
| Q3 25 | -32.7% | 20.7% | ||
| Q2 25 | -40.9% | -7.3% | ||
| Q1 25 | -52.8% | 10.0% | ||
| Q4 24 | -177.8% | 23.9% | ||
| Q3 24 | -354.8% | -11.2% | ||
| Q2 24 | -120.3% | -0.5% | ||
| Q1 24 | -322.7% | -0.5% |
| Q4 25 | $0.03 | $2.34 | ||
| Q3 25 | $-0.13 | $7.76 | ||
| Q2 25 | $-0.16 | $-2.95 | ||
| Q1 25 | $-0.20 | $3.33 | ||
| Q4 24 | $-0.68 | $11.56 | ||
| Q3 24 | $-1.34 | $-1.72 | ||
| Q2 24 | $-0.54 | $-0.07 | ||
| Q1 24 | $-1.46 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $540.9M | $185.6M |
| Total DebtLower is stronger | $9.7B | — |
| Stockholders' EquityBook value | $4.6B | $329.4M |
| Total Assets | $15.0B | $918.5M |
| Debt / EquityLower = less leverage | 2.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $540.9M | $185.6M | ||
| Q3 25 | $396.6M | $166.0M | ||
| Q2 25 | $509.8M | $96.7M | ||
| Q1 25 | $673.5M | $84.7M | ||
| Q4 24 | $332.3M | $40.6M | ||
| Q3 24 | $275.6M | $46.9M | ||
| Q2 24 | $606.5M | $40.8M | ||
| Q1 24 | $224.3M | $30.0M |
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.6B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $9.5B | — | ||
| Q4 24 | $8.8B | — | ||
| Q3 24 | $9.2B | — | ||
| Q2 24 | $9.4B | — | ||
| Q1 24 | $10.1B | — |
| Q4 25 | $4.6B | $329.4M | ||
| Q3 25 | $4.7B | $317.2M | ||
| Q2 25 | $4.8B | $235.3M | ||
| Q1 25 | $4.8B | $176.9M | ||
| Q4 24 | $4.8B | $132.4M | ||
| Q3 24 | $5.4B | $60.4M | ||
| Q2 24 | $6.2B | $62.7M | ||
| Q1 24 | $6.7B | $63.0M |
| Q4 25 | $15.0B | $918.5M | ||
| Q3 25 | $14.9B | $964.5M | ||
| Q2 25 | $15.2B | $841.0M | ||
| Q1 25 | $14.9B | $761.9M | ||
| Q4 24 | $14.3B | $655.3M | ||
| Q3 24 | $15.2B | $438.5M | ||
| Q2 24 | $16.2B | $422.4M | ||
| Q1 24 | $17.3B | $404.3M |
| Q4 25 | 2.11× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | 2.00× | — | ||
| Q1 25 | 1.99× | — | ||
| Q4 24 | 1.83× | — | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 1.51× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.8M | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 13.11× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.8M | $70.4M | ||
| Q3 25 | $18.6M | $99.5M | ||
| Q2 25 | $51.7M | $27.3M | ||
| Q1 25 | $384.0K | $51.0M | ||
| Q4 24 | $245.5M | $54.0K | ||
| Q3 24 | $59.2M | $6.8M | ||
| Q2 24 | $35.3M | $13.3M | ||
| Q1 24 | $74.3M | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | 13.11× | 5.95× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.40× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MPW
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
